ExxonMobil Modifies Facilities to Produce Medical-Grade Sanitizer for COVID-19 Response
April 24 2020 - 7:00AM
Business Wire
- Product to be donated to health care providers and first
responders across the United States
- Equipment modified to enable Baton Rouge area facilities to
produce, blend, package and distribute sanitizer
- Targeting production of 160,000 gallons of sanitizer, enough
for nearly 5 million bottles
ExxonMobil said today it has reconfigured manufacturing
operations in Louisiana to produce medical-grade hand sanitizer for
donation to COVID-19 response efforts in Louisiana, New Jersey, New
Mexico, New York, Pennsylvania and Texas.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200424005081/en/
To enhance safety, ExxonMobil plant
personnel package the sanitizers outdoors. The new manufacturing
process upholds all safety requirements and the consumer-ready
product meets FDA standards. (Photo: Business Wire)
Initial production of 160,000 gallons of medical grade sanitizer
– enough to fill nearly 5 million 4-ounce bottles – is being
distributed to medical providers and first responders. Additional
donation locations are planned.
“The ingenuity and dedication of our employees to develop a
consumer-ready product in record time demonstrates ExxonMobil’s
commitment to help those in need during the global pandemic,” said
Darren Woods, chairman and chief executive officer of Exxon Mobil
Corporation. “We’re focused on keeping our people and communities
safe while supporting frontline responders and meeting customer
needs.”
ExxonMobil has increased monthly production of isopropyl alcohol
-- a key ingredient in sanitizer – by about 3,000 tonnes at its
chemical manufacturing facility in Baton Rouge, Louisiana. To
produce, package and distribute hand sanitizer, the company
purchased additional ingredients and modified equipment in Baton
Rouge and at a lubricants plant in nearby Port Allen,
Louisiana.
“To stand up an entirely new process and supply chain in a
matter of weeks, while maintaining ExxonMobil’s high standards for
safety and quality and in compliance with FDA requirements is truly
remarkable,” said Karen McKee, president of ExxonMobil Chemical
Company.
Earlier this month, ExxonMobil announced the increased
production of isopropyl alcohol, which is enough to enable monthly
production of up to 50 million 4-ounce bottles of sanitizer. The
company also increased its capability to manufacture specialized
polypropylene, used in medical masks and gowns, by about 1,000
tonnes per month, which is enough to enable production of up to 200
million medical masks or 20 million gowns.
ExxonMobil is also participating in a technology collaboration
with the Global Center for Medical Innovation to rapidly redesign
and manufacture reusable personal protection equipment, such as
medical face shields and masks.
About ExxonMobil
ExxonMobil, one of the largest publicly traded international
energy companies, uses technology and innovation to help meet the
world’s growing energy needs. ExxonMobil holds an industry-leading
inventory of resources, is one of the largest refiners and
marketers of petroleum products, and its chemical company is one of
the largest in the world. To learn more, visit exxonmobil.com and
the Energy Factor.
Follow us on Twitter and LinkedIn.
Cautionary Statement: Statements of
future events or conditions in this release are forward-looking
statements. Actual future results, our production capacity, and the
impact of the COVID-19 pandemic on ExxonMobil’s business and
results could vary significantly depending on a number of factors
including the supply and demand for oil, gas, and petroleum
products and other market factors affecting oil, gas, petrochemical
and feedstock prices; the outcome of government policies and
actions, including actions taken to address COVID-19 and to
maintain the functioning of national and global economies and
markets; the severity, length and ultimate impact of COVID-19 on
people and economies; the outcome of further research and testing;
the development and competitiveness of alternative technologies;
the impact of company actions to protect the health and safety of
employees, vendors, customers, and communities; actions of
competitors and commercial counterparties; the ability to scale
pilot projects on a cost-effective basis; political and regulatory
developments including actions that may favor certain types of
technologies over others; the outcome of commercial negotiations;
and other factors discussed under Item 1A Risk Factors in
ExxonMobil’s most recent annual report on Form 10-K and set forth
under the heading “Factors Affecting Future Results” on the
Investors page of our website at exxonmobil.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200424005081/en/
ExxonMobil Media Relations: (972) 940-6007
Exxon Mobil (NYSE:XOM)
Historical Stock Chart
From Apr 2024 to May 2024
Exxon Mobil (NYSE:XOM)
Historical Stock Chart
From May 2023 to May 2024